PL2014771T3 - Ciągły proces hydrolizy enzymatycznej - Google Patents
Ciągły proces hydrolizy enzymatycznejInfo
- Publication number
- PL2014771T3 PL2014771T3 PL07110957T PL07110957T PL2014771T3 PL 2014771 T3 PL2014771 T3 PL 2014771T3 PL 07110957 T PL07110957 T PL 07110957T PL 07110957 T PL07110957 T PL 07110957T PL 2014771 T3 PL2014771 T3 PL 2014771T3
- Authority
- PL
- Poland
- Prior art keywords
- enzymatic hydrolysis
- hydrolysis process
- continuous enzymatic
- continuous
- hydrolysis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/38—Nucleosides
- C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07110957.3A EP2014771B1 (en) | 2007-06-25 | 2007-06-25 | Continuous enzymatic hydrolysis process |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2014771T3 true PL2014771T3 (pl) | 2015-05-29 |
Family
ID=39111421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07110957T PL2014771T3 (pl) | 2007-06-25 | 2007-06-25 | Ciągły proces hydrolizy enzymatycznej |
Country Status (14)
Country | Link |
---|---|
US (2) | US20110091943A1 (pl) |
EP (1) | EP2014771B1 (pl) |
JP (1) | JP5559046B2 (pl) |
CN (1) | CN101720333B (pl) |
AU (1) | AU2008268384B2 (pl) |
CA (1) | CA2692437C (pl) |
DK (1) | DK2014771T3 (pl) |
ES (1) | ES2530763T3 (pl) |
HK (1) | HK1126820A1 (pl) |
MX (1) | MX2009014280A (pl) |
PL (1) | PL2014771T3 (pl) |
SI (1) | SI2014771T1 (pl) |
TW (1) | TWI438280B (pl) |
WO (1) | WO2009003042A1 (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014014740B1 (pt) | 2011-12-22 | 2021-08-24 | Alios Biopharma, Inc | Compostos de nucleosídeos, nucleotídeos e análogos destes, seu uso e composição farmacêutica |
USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
SG11201407336PA (en) | 2012-05-25 | 2015-03-30 | Janssen Sciences Ireland Uc | Uracyl spirooxetane nucleosides |
CA2894542C (en) | 2012-12-21 | 2023-10-31 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
TW201524990A (zh) | 2013-10-11 | 2015-07-01 | Alios Biopharma Inc | 經取代之核苷、核苷酸及其類似物 |
AU2016229966B2 (en) | 2015-03-06 | 2018-09-27 | Atea Pharmaceuticals, Inc. | Beta-D-2'-deoxy-2'alpha-fluoro-2'-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment |
KR102456417B1 (ko) | 2016-09-07 | 2022-10-19 | 아테아 파마슈티컬즈, 인크. | Rna 바이러스 치료를 위한 2'-치환된-n6-치환된 퓨린 뉴클레오티드 |
CN110248951B (zh) | 2017-02-01 | 2022-10-28 | 阿堤亚制药公司 | 用于治疗丙型肝炎病毒的核苷酸半硫酸盐 |
KR20200140865A (ko) | 2018-04-10 | 2020-12-16 | 아테아 파마슈티컬즈, 인크. | 간경변증을 갖는 hcv 감염 환자의 치료 |
US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3836432A (en) * | 1969-09-25 | 1974-09-17 | Hokkaido Sugar Co | Continuous process for the hydrolysis of raffinose |
FR2648147B1 (fr) * | 1989-06-13 | 1991-08-16 | Gattefosse Ets Sa | Procede pour la preparation de beta-monoglycerides et produits obtenus |
US5538891A (en) * | 1991-09-02 | 1996-07-23 | Boehringer Mannheim Gmbh | Process for enzymatic production of isomerically pure isosorbide-2 and 5-monoesters and their conversion to isosorbide-2 and -5 nitrate |
US5686426A (en) * | 1994-11-17 | 1997-11-11 | Bristol-Myers Squibb Company | Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
US6833471B2 (en) * | 2002-09-09 | 2004-12-21 | Biocatalytics, Inc. | Methods for producing hydroxy amino acids and derivatives thereof |
US20080070852A1 (en) * | 2004-06-07 | 2008-03-20 | Averett Devron R | 3-Beta-D-Ribofuranosylthiazolo[ 4,5-D] Pyridimine Nucleosides and Uses Thereof |
DE102005002700A1 (de) * | 2005-01-19 | 2006-07-27 | Cognis Deutschland Gmbh & Co. Kg | Zusammensetzungen verwendbar als Biotreibstoff |
-
2007
- 2007-06-25 ES ES07110957T patent/ES2530763T3/es active Active
- 2007-06-25 DK DK07110957T patent/DK2014771T3/en active
- 2007-06-25 EP EP07110957.3A patent/EP2014771B1/en not_active Not-in-force
- 2007-06-25 SI SI200731620T patent/SI2014771T1/sl unknown
- 2007-06-25 PL PL07110957T patent/PL2014771T3/pl unknown
-
2008
- 2008-06-24 TW TW097123430A patent/TWI438280B/zh not_active IP Right Cessation
- 2008-06-25 CN CN2008800216422A patent/CN101720333B/zh not_active Expired - Fee Related
- 2008-06-25 CA CA2692437A patent/CA2692437C/en not_active Expired - Fee Related
- 2008-06-25 MX MX2009014280A patent/MX2009014280A/es active IP Right Grant
- 2008-06-25 WO PCT/US2008/068197 patent/WO2009003042A1/en active Application Filing
- 2008-06-25 JP JP2010515081A patent/JP5559046B2/ja not_active Expired - Fee Related
- 2008-06-25 US US12/666,597 patent/US20110091943A1/en not_active Abandoned
- 2008-06-25 AU AU2008268384A patent/AU2008268384B2/en not_active Ceased
-
2009
- 2009-07-06 HK HK09106063.0A patent/HK1126820A1/xx not_active IP Right Cessation
-
2013
- 2013-01-22 US US13/747,138 patent/US20130137143A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK2014771T3 (en) | 2015-03-09 |
TWI438280B (zh) | 2014-05-21 |
ES2530763T3 (es) | 2015-03-05 |
JP5559046B2 (ja) | 2014-07-23 |
CA2692437A1 (en) | 2008-12-31 |
MX2009014280A (es) | 2010-06-23 |
TW200911997A (en) | 2009-03-16 |
US20130137143A1 (en) | 2013-05-30 |
WO2009003042A1 (en) | 2008-12-31 |
US20110091943A1 (en) | 2011-04-21 |
AU2008268384B2 (en) | 2013-09-26 |
HK1126820A1 (en) | 2009-09-11 |
CN101720333B (zh) | 2012-08-29 |
CN101720333A (zh) | 2010-06-02 |
CA2692437C (en) | 2016-04-19 |
EP2014771B1 (en) | 2014-12-03 |
AU2008268384A1 (en) | 2008-12-31 |
JP2011500001A (ja) | 2011-01-06 |
SI2014771T1 (sl) | 2015-04-30 |
EP2014771A1 (en) | 2009-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1126820A1 (en) | Continuous enzymatic hydrolysis process | |
SG10201506935QA (en) | Enzymatic process | |
GB0711624D0 (en) | Process | |
GB0706978D0 (en) | Process | |
GB0700074D0 (en) | process | |
EP2152631A4 (en) | NICKEL LATERITE PROCEDURE | |
PL2772543T3 (pl) | Enzymatyczny proces wytwarzania beta-santalenu i odpowiadającego mu enzymu | |
GB0711680D0 (en) | Process | |
EP2229583A4 (en) | Monitoring enzymatic process | |
IL190914A0 (en) | Production of dolasetron | |
GB0714390D0 (en) | Process | |
GB0700878D0 (en) | Process | |
GB0818328D0 (en) | Novel enzyme | |
GB0804721D0 (en) | Enzyme | |
GB0803628D0 (en) | Enzyme | |
GB0709689D0 (en) | Process | |
GB0804722D0 (en) | Enzyme | |
GB0719251D0 (en) | Process | |
GB0800831D0 (en) | Enzymes 1 | |
GB0701966D0 (en) | Process | |
HU0700089D0 (en) | Hydrolysis | |
AU2008903814A0 (en) | Enzyme hydrolysis method | |
GB0903266D0 (en) | Enzymatic process | |
GB0910808D0 (en) | Enzymatic process | |
GB0800832D0 (en) | Enzymes 2 |